What Is With This Cough? | ShortenYourColds.com

You had a cold. It lasted about a week, maybe ten days. You felt better. And then the cough stuck around. You're not congested anymore. You don't have a fever. You don't feel sick. But every time you try to have a conversation, lie down at night, or take a deep breath, there it is.

You're not imagining it. And nothing is wrong with you. What you're dealing with has a name — post-infectious cough — and the most important thing to know about it is that it is supposed to do exactly this. Linger. Annoy you. Make you wonder if something was missed. It wasn't.

Your immune system did its job. The virus is gone. The cough is the last chapter of that story — and it will end.

Your airways went through something — inflammation, irritation, weeks of your body fighting back — and they don't just snap back to normal the moment the infection clears. The cough reflex, which is one of your body's most automatic responses, stays on a hair trigger for a while. That's not a malfunction. That's the tail end of a normal recovery.

Many people expect a cold to be over in a week. The cough that follows can last two to four weeks in many people — and for about one in five, closer to a month. That's not a sign that you need an antibiotic. It's a sign that your body is finishing what it started.

So Do You Need an Antibiotic?

Almost certainly not. More than 90% of these coughs are caused by a virus — and antibiotics don't treat viruses. They treat bacteria. Taking an antibiotic for a viral cough doesn't shorten it, doesn't make you feel better faster, and does carry real risks — digestive upset, rash, and contributing to antibiotic resistance that affects all of us.

The research on this is not subtle. A review of 17 clinical trials found no demonstration of clinically significant benefit from antibiotics for this type of cough — with a meaningful increase in side effects. That trade-off is not worth it — and your doctor knows this.

How Long Does a Cough Actually Last?

Probably longer than you think — and longer than most doctors tell patients. Research finds the mean duration of cough from a respiratory infection is 16.4 days. About one in five people will still be coughing at three weeks. That is not a sign something went wrong. That is the normal distribution of a normal recovery.

What Actually Helps

The honest answer is that nothing makes post-infectious cough disappear overnight. But there is plenty you can do to make the days more manageable — and one thing above all else that will get you through it: treating whatever is still driving the cough.

For many people, the cough is being kept alive by residual nasal congestion and postnasal drip. The cold is gone but the nose hasn't fully settled down yet, and that drip hitting the back of your throat is triggering the cough reflex over and over. Treating the nasal symptoms aggressively is often the single most effective thing you can do.

During the Day

A non-drowsy antihistamine and decongestant combination — available over the counter, kept behind the pharmacy counter because it contains pseudoephedrine — addresses both the inflammation in the nasal lining and the congestion that is feeding the drip. Use with caution if you have prostate or bladder issues, high blood pressure, or heart problems. Ask your pharmacist if you are unsure.

Lozenges help. Hot non-dairy beverages help. A humidifier in the bedroom helps. None of these will cure the cough, but they coat and soothe irritated airways, keep things hydrated, and give your body the conditions it needs to finish recovering.

Getting Through the Night

This is where many people struggle hardest. Lying down shifts drainage patterns, the house is quiet, and every cough feels louder and more relentless than it did during the day.

For nighttime, switch to a first-generation antihistamine-containing product. The mild sedating effect is not a side effect here — it is the point. Good sleep medicine is good cough medicine. Getting a full night of rest is not a luxury. It is part of the recovery.

R.W. Raskinism

Carefully knock yourself out.

Raskin's Cough Cocktail

Approximately three-quarters seltzer/club soda, remainder orange juice. Serve on ice.

The carbonation provides a brief sensory interruption to the cough reflex. The citrus adds palatability and a modest immune-supportive rationale. Simple, accessible, and gives you something active to reach for instead of the cough syrup aisle.

This is an addition to your hot beverage routine — not a replacement for it.

What About Cough Medicine?

Many products labeled "cough suppressant" do not deliver what the label implies. Cough is a reflex — one of your body's most automatic responses — and genuinely suppressing a reflex requires a level of intervention that no over-the-counter product comes close to. What these products offer is, at best, a modest dampening effect with a ceiling well below what the packaging suggests.

Honey is the one agent that has shown some benefit for cough — studied in children, but adults can try it too. A spoonful in decaffeinated tea before bed is a simple, low-risk option worth reaching for. Do not give honey to infants under twelve months.

When Should You Actually Call Your Doctor?

Post-infectious cough is self-limiting. It resolves on its own. But there are signs that something else may be going on and that a call or visit is warranted.

Reach out if you experience

Coughing up blood
Significant shortness of breath
High fever returning after you thought you were better
Unexplained weight loss
A cough that is clearly getting worse rather than slowly improving
A cough that has not improved at all by eight weeks

R.W. Raskinism

When in doubt, get checked out.

If there is one thing to take away from this article, it is this: your doctor is not withholding treatment when they don't prescribe an antibiotic for your cough. They are practicing good medicine. The research is clear, the guidelines are clear, and well more than a decade of experience dealing almost exclusively with upper respiratory issues has taught me that the patients who do best are the ones who understand what is happening.

You had a cold. Your body fought it off. The cough is the last chapter of that story. It will end. The best prescription your doctor can write you is time. A little patience. And the trust to let your body finish what it already started.

The Defense

Still recovering? That's ZnPaC's territory. When you're back to baseline — that's when SYC begins. The goal of SYC is to keep you off the arc in the first place.

Join the Movement

Your doctor should be getting this right. Now you'll know when they're not.

Before you get sick, get SYC →

You don't need an antibiotic for a cold. You need a plan.

For Clinicians

The clinician version covers the evidence, the mechanisms, the guidelines, and the prescribing data in full. You're allowed to read that one too. Read the clinician version →

For informational and educational purposes only. Does not constitute medical advice. When in doubt, get checked out.

For Clinicians

You managed it right. No antibacterials, supportive care, appropriate expectations. Your patient felt better — and then called back. The cold resolved. The cough didn't. Now they're sitting in front of you again, or on the phone, convinced they need an antibiotic.

Nothing was missed. This is what post-infectious cough does. It persists. It lingers past the point where the illness feels like it should be over. And the gap between what patients expect and what the biology actually delivers is responsible for an enormous amount of unnecessary prescribing — prescribing that doesn't shorten the cough, does carry real adverse event risk, and teaches the patient exactly the wrong lesson about what their body needs.

The Central Clinical Problem

Post-infectious cough is self-limiting. In most patients it requires nothing beyond reassurance and time. The evidence base for any pharmacologic intervention — antibacterials, corticosteroids, bronchodilators, antitussives — is remarkably thin across the board. The single most effective intervention is setting accurate expectations at the initial visit, before the callback happens.

How Long Does a Cough Actually Last?

The data on cough duration are probably not what you were taught — and almost certainly not what your patients believe.

A large prospective US cohort study found the mean duration of cough from lower respiratory tract infection was 16.4 days. The more important finding: pathogen type was not a meaningful predictor. Viral cough resolved in 14.7 days on average, bacterial in 17.3 days, mixed in 16.9 days. There is no biological signal in that spread — and no clinical justification for empiric antibacterial therapy based on symptom duration alone.

An individual patient data analysis of over 9,000 patients identified four distinct recovery trajectories. The group that generates the callback — the slow recoverers — represents about 19% of patients, with cough lasting roughly 27 days. They are not outliers. They are within the normal distribution of a self-resolving process.

Recovery Trajectories — 9,000+ Patients · Hounkpatin et al. 2023

52%

~6 days
Rapid recovery

29%

~10 days
Intermediate

19%

~27 days
Slow — the callback group

90%

by day 28
Recovered regardless of Abx

Ebell MH et al. Clin Microbiol Infect. 2024. · In children: 90% resolution by day 25 (Thompson et al. BMJ. 2013).

What You're Actually Dealing With

Post-infectious cough — the 3-to-8-week window — results from cough reflex hypersensitivity driven by residual airway inflammation. Inflammatory mediators act on sensory nerve endings in the larynx and lower airways long after the pathogen itself is gone. This is a self-resolving neuroimmune process. Not an ongoing infection. Treating it as one is where the prescribing errors begin.

Upper airway cough syndrome (UACS, formerly postnasal drip syndrome) overlaps with this picture in a clinically important way. Ongoing nasal congestion and postnasal drip are among the most common perpetuators of post-viral cough — and unlike the cough reflex hypersensitivity itself, the nasal component is something you can actually treat.

What Doesn't Work

The list of studied-and-ineffective interventions for post-infectious cough is longer than most clinicians realize — and includes several that are still being prescribed reflexively.

Intervention	Evidence	Verdict
Antibacterials	17 RCTs — no clinically significant benefit; increased adverse events	No benefit
Oral corticosteroids	No RCT evidence for post-infectious cough specifically	Not supported
Inhaled corticosteroids	Cochrane 2013 — no significant reduction in cough duration	Not supported
Dextromethorphan	Outperformed by honey in pediatric studies; meaningful drug interaction burden (serotonin syndrome with SSRIs, MAOIs, tramadol)	Not recommended
Codeine	Two RCTs — no benefit vs. placebo at clinical doses (P=0.23 at 30mg QID × 4 days)	No efficacy signal
Ipratropium/salbutamol	One RCT — meaningful daytime cough reduction at day 10 in post-viral airway hyperreactivity	Targeted use only
Honey	Cochrane 2018 — benefit shown in children; reasonable low-risk adult option	Reasonable option

On Narcotic Antitussives

I have moved away from prescribing narcotic cough suppressants for post-infectious cough, and the data support that position clearly. Codeine was tested in two RCTs for acute cough and was no more effective than placebo in either. Hydrocodone remains FDA-approved for cough suppression in adults, but the primary supporting data come from a single phase II trial of 20 patients with cancer-related cough. The FDA has issued boxed warnings covering addiction, abuse, and respiratory depression — and in 2018 restricted both codeine and hydrocodone cough products in patients under 18.

Managing Expectations — The Intervention That Actually Works

One of the most important clinical lessons I have learned is this: if you can adequately manage a patient's expectations while providing genuine reassurance, you can practice good medicine in the background. The visit does not need to produce a prescription. It needs to produce a patient who understands what is happening and what to watch for.

One study found an 85% decrease in antibacterial prescribing when providers explained the evidence and gave clear symptomatic guidance. Patient satisfaction tracked with feeling heard and getting an explanation — not with receiving a prescription. The quality of the encounter is the product.

Practical language: calling it a "chest cold" rather than "bronchitis" reduces prescribing pressure. A written handout on expected cough duration reduces callbacks from the 19% of patients who will still be coughing at three weeks. A postdated prescription, used judiciously in genuinely uncertain cases, can hold the relationship without defaulting to empiric therapy.

What I Actually Do

My approach is built around one question: what is driving or worsening this cough, and can I treat that? For the vast majority of post-infectious cough, the answer is residual nasal congestion and postnasal drip. That is where I put my clinical energy.

I tend to recommend a second-generation antihistamine combined with a pseudoephedrine decongestant — 12- or 24-hour formulation — used with appropriate caution in patients with prostate or bladder issues. Second-generation antihistamines block H1 receptors in the nasal mucosa, reducing histamine-driven inflammation, swelling, and secretion — the exact pathways perpetuating the drip that is driving the cough.

For nighttime, I shift to a first-generation antihistamine-containing product. For those really tough nights, I tend to tack on diphenhydramine in the evening. Good cough medicine is good sleep medicine, and for many patients the primary goal is simply getting through the night.

For bronchospasm — patients with clear evidence of post-viral airway hyperreactivity — the ipratropium/salbutamol combination has one RCT showing meaningful daytime cough reduction at day 10. Not a routine prescription, but a targeted one when the clinical picture fits.

R.W. Raskinism

Carefully tell your patients to carefully knock themselves out.

Beyond pharmacology, I am a strong advocate for lozenges, hot non-dairy beverages, and humidifiers. The mechanism is sound — throat coating, mucosal hydration, reduced irritant exposure — and the risk profile is zero. Patients want to do something. Give them something safe and sensible to do.

Raskin's Cough Cocktail

Approximately three-quarters seltzer/club soda, remainder orange juice. Serve cold or at room temperature.

The carbonation provides a brief sensory interruption to the cough reflex. The vitamin C and citric acid add palatability and a modest immune-supportive rationale. This is an addition to the hot beverage recommendation — not a replacement for it.

What I actively talk patients out of: anything labeled "cough suppressant." The label implies a level of pharmacologic effect these products do not deliver for post-infectious cough, and it positions the cough — a self-resolving reflex response — as something that needs to be chemically controlled rather than outlasted.

When to Reassess

Eight weeks is the line. Cough that crosses it moves out of the post-infectious category and into chronic cough territory, where UACS, cough-variant asthma, and GERD account for the vast majority of cases.

Before eight weeks, earlier reassessment is warranted for: hemoptysis, significant dyspnea, unexplained weight loss, night sweats, immunocompromised status, high-risk exposure history, or cough that is clearly worsening rather than plateauing. Those are not post-infectious cough. They are a different conversation entirely.

For Patients

The patient-facing version is available at ShortenYourColds.com. The clinician version isn't just for clinicians — if your patient wants the full picture, the evidence, the mechanism, the history, it's all there. They're allowed to know this. Read the patient version →

References

Ebell MH et al. Clin Microbiol Infect. 2024;30(12):1569–1575.
Hounkpatin H et al. Br J Gen Pract. 2023;73(728):e196–e203.
Smith SM et al. Cochrane Database Syst Rev. 2017;6:CD000245.
Ebell MH et al. J Gen Intern Med. 2025. doi:10.1007/s11606-025-09733-x.
Johnstone KJ et al. Cochrane Database Syst Rev. 2013;(3):CD009305.
Malesker MA et al. Chest. 2017;152(5):1021–1037.
Smith MP et al. Chest. 2020;157(5):1256–1265.
Harris AM et al. Ann Intern Med. 2016;164(6):425–434.
Zanasi A et al. Pulm Pharmacol Ther. 2014;29(2):224–232.
Speich B et al. Br J Gen Pract. 2018;68(675):e694–e702.
Irwin RS et al. Chest. 2018;153(1):196–209.
Thompson M et al. BMJ. 2013;347:f7027.
Oduwole O et al. Cochrane Database Syst Rev. 2018;4:CD007094.
Smith SM et al. Cochrane Database Syst Rev. 2014;(11):CD001831.
Molassiotis A et al. Chest. 2017;151(4):861–874.
Chua KP, Conti RM. JAMA Netw Open. 2021;4(11):e2134142.

For informational and educational purposes only. Clinical judgment applies in all patient encounters.